MyFinsight
Home
About
Contact
vrtx: the income statement
Download
Download image
Other Countries
Outsideofthe United...
$263,200K
Europe
$836,900K
Non Us
$1,100,100K
US
$1,976,300K
Product
$3,076,400K
Total revenues
$3,076,400K
(10.99%↑ Y/Y)
Interest income
$125,700K
(-4.92%↓ Y/Y)
Income (loss) from
operations
$1,186,200K
(6.26%↑ Y/Y)
Total costs and
expenses
$1,890,200K
(14.17%↑ Y/Y)
Change in fair value of
contingent consideration
-$1,900K
(-733.33%↓ Y/Y)
Income (loss) before
provision for income taxes
$1,298,800K
(6.10%↑ Y/Y)
Other expense, net
-$9,800K
(42.01%↑ Y/Y)
Interest expense
$3,300K
(-56.00%↓ Y/Y)
Selling, general and
administrative expenses
$445,100K
(19.71%↑ Y/Y)
Acquired in-process
research and development...
$54,500K
(263.33%↑ Y/Y)
Research and development
expenses
$977,700K
(11.62%↑ Y/Y)
Cost of sales
$414,800K
(5.65%↑ Y/Y)
Net income (loss)
$1,082,900K
(3.59%↑ Y/Y)
Provision for income taxes
$215,900K
(20.82%↑ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
logo-vertex-inc-svg copy-svg
VERTEX PHARMACEUTICALS INC MA (VRTX)
logo-vertex-inc-svg copy-svg
VERTEX PHARMACEUTICALS INC MA (VRTX)